The DOI matches its Crossref record.
20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension
Open accessAbstract
Arachidonic acid is metabolized by enzymes of the CYP4A and 4F families to 20-hydroxyeicosatetraeonic acid (20-HETE), which plays an important role in the regulation of renal function, vascular tone, and the long-term control of arterial pressure. In the vasculature, 20-HETE is a potent vasoconstrictor, and upregulation of the production of this compound contributes to the elevation in oxidative stress and endothelial dysfunction and the increase in peripheral vascular resistance associated with some forms of hypertension. In kidney, 20-HETE inhibits Na transport in the proximal tubule and thick ascending loop of Henle, and deficiencies in the renal formation of 20-HETE contributes to sodium retention and development of some salt-sensitive forms of hypertension. 20-HETE also has renoprotective actions and opposes the effects of transforming growth factor β to promote proteinuria and renal end organ damage in hypertension. Several new inhibitors of the synthesis of 20-HETE and 20-HETE agonists and antagonists have recently been developed. These compounds along with peroxisome proliferator-activated receptor-α agonists that induce the renal formation of 20-HETE seem to have promise as antihypertensive agents. This review summarizes the rationale for the development of drugs that target the 20-HETE pathway for the treatment of hypertension and associated cardiovascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
Morisseau, C., & Hammock, B. D. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140244 · Cited by 537
Arachidonic Acid Metabolism and Kidney Inflammation
Wang, T., Fu, X., Chen, Q., Patra, J. K., Wang, D., Wang, Z., & Gai, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153683 · Cited by 430
Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology
Imig, J. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00021.2011 · Cited by 365
Adenosine A1 Receptors Link to Smooth Muscle Contraction Via CYP4a, protein kinase C-α, and ERK1/2
Kunduri, S. S., Mustafa, S. J., Ponnoth, D. S., Dick, G. M., & Nayeem, M. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182919591 · Cited by 30
GPR75: an exciting new target in metabolic syndrome and related disorders
Murtaza, B., Asghar, F., & Patoli, D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.005 · Cited by 18
Metadata
- Authors
- Williams, J. M., Murphy, S., Burke, M., & Roman, R. J.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2010-10
- Volume
- 56
- Issue
- 4
- Pages
- 336-344
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W2034628038
- Cited by
- 169
- References
- 0
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension. https://app.cochat.ai/papers/10.1097/fjc.0b013e3181f04b1c
- The paper
- Williams, J. M., Murphy, S., Burke, M., & Roman, R. J. (2010). 20-Hydroxyeicosatetraeonic Acid: A New Target for the Treatment of Hypertension. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0b013e3181f04b1c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.